UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Does pharmacologically induced weight. loss improve cardiovascular outcome? Impact of anti-obesity agents on cardiovascular risk factors

Finer, N; (2005) Does pharmacologically induced weight. loss improve cardiovascular outcome? Impact of anti-obesity agents on cardiovascular risk factors. EUROPEAN HEART JOURNAL SUPPLEMENTS , 7 (L) L32-L38. 10.1093/eurheartj/sui084.

Full text not available from this repository.
Type: Article
Title: Does pharmacologically induced weight. loss improve cardiovascular outcome? Impact of anti-obesity agents on cardiovascular risk factors
DOI: 10.1093/eurheartj/sui084
Keywords: Science & Technology, Life Sciences & Biomedicine, Cardiac & Cardiovascular Systems, Cardiovascular System & Cardiology, anti-obesity drugs, cardiovascular risk, HDL-cholesterol, metabolic risk, obesity, Orlistat, rimonabant, risk factors, sibutramine, weight loss, ENERGY-EXPENDITURE, RANDOMIZED-TRIAL, OBESE-PATIENTS, SIBUTRAMINE, ORLISTAT, MAINTENANCE, PREVENTION, REDUCTION, FAT
UCL classification: UCL > Provost and Vice Provost Offices
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Pop Health Sciences > Institute of Cardiovascular Science
URI: http://discovery.ucl.ac.uk/id/eprint/1357439
Downloads since deposit
0Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item